SUBSCRIBE TO PE HUB WIRE
Join over 70,000 of your peers
Get the must-read email for PE/VC professionals delivered to your inbox daily
— for free!
TAE Life Sciences fetches $40 mln Series A in ARTIS Ventures-led round
TAE Life Sciences, a developer of treatments for difficult to treat cancers, has raised $40 million in Series A funding. ARTIS Ventures led the round.
Source: Press Release
PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.
Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!